Company · CIK 1826457

# Monte Rosa Therapeutics, Inc.

| CIK | [1826457](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001826457) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | MA |
| Listed | GLUE (Nasdaq) |
| First annual or quarterly report | 2021-08-12 |

## Offerings

 4 registrations

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-293389 | Shelf Effective | 2026-02-11 | 2026-02-11 | 1 |
| 333-285942 | Shelf Effective | 2025-03-20 | 2026-01-09 | 4 |
| 333-266003 | Shelf Effective | 2022-07-01 | 2024-05-16 | 5 |
| 333-256773 | IPO Final prospectus | 2021-06-04 | 2021-06-25 | 5 |

## Filings

 16

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-02-11 | [S-3ASR](https://www.sec.gov/Archives/edgar/data/1826457/000119312526046690/0001193125-26-046690-index.htm) Shelf registered | 333-293389 | 0001193125-26-046690 |
| 2026-01-09 | [424B5](https://www.sec.gov/Archives/edgar/data/1826457/000119312526009001/0001193125-26-009001-index.htm) Shelf takedown | 333-285942 | 0001193125-26-009001 |
| 2026-01-07 | [424B5](https://www.sec.gov/Archives/edgar/data/1826457/000119312526006297/0001193125-26-006297-index.htm) Shelf takedown | 333-285942 | 0001193125-26-006297 |
| 2025-03-31 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1826457/999999999525000901/9999999995-25-000901-index.htm) Declared effective | 333-285942 | 9999999995-25-000901 |
| 2025-03-20 | [S-3](https://www.sec.gov/Archives/edgar/data/1826457/000119312525058423/0001193125-25-058423-index.htm) Shelf registered | 333-285942 | 0001193125-25-058423 |
| 2024-05-16 | [424B5](https://www.sec.gov/Archives/edgar/data/1826457/000119312524140518/0001193125-24-140518-index.htm) Shelf takedown | 333-266003 | 0001193125-24-140518 |
| 2024-05-15 | [424B5](https://www.sec.gov/Archives/edgar/data/1826457/000119312524139354/0001193125-24-139354-index.htm) Shelf takedown | 333-266003 | 0001193125-24-139354 |
| 2023-10-26 | [424B5](https://www.sec.gov/Archives/edgar/data/1826457/000119312523264155/0001193125-23-264155-index.htm) Shelf takedown | 333-266003 | 0001193125-23-264155 |
| 2022-07-13 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1826457/999999999522002061/9999999995-22-002061-index.htm) Declared effective | 333-266003 | 9999999995-22-002061 |
| 2022-07-01 | [S-3](https://www.sec.gov/Archives/edgar/data/1826457/000119312522187284/0001193125-22-187284-index.htm) Shelf registered | 333-266003 | 0001193125-22-187284 |
| 2021-06-25 | [424B4](https://www.sec.gov/Archives/edgar/data/1826457/000119312521199386/0001193125-21-199386-index.htm) Final prospectus | 333-256773 | 0001193125-21-199386 |
| 2021-06-23 | [EFFECT](https://www.sec.gov/Archives/edgar/data/1826457/999999999521002471/9999999995-21-002471-index.htm) Declared effective | 333-256773 | 9999999995-21-002471 |
| 2021-06-21 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1826457/000119312521194056/0001193125-21-194056-index.htm) Amendment | 333-256773 | 0001193125-21-194056 |
| 2021-06-09 | [S-1/A](https://www.sec.gov/Archives/edgar/data/1826457/000119312521186830/0001193125-21-186830-index.htm) Amendment | 333-256773 | 0001193125-21-186830 |
| 2021-06-04 | [S-1](https://www.sec.gov/Archives/edgar/data/1826457/000119312521182268/0001193125-21-182268-index.htm) Registration filed | 333-256773 | 0001193125-21-182268 |
| 2021-04-19 | [DRS](https://www.sec.gov/Archives/edgar/data/1826457/000095012321004703/0000950123-21-004703-index.htm) Draft made public | 377-04684 | 0000950123-21-004703 |

[All filings of this company](https://equitycapital.markets/filings?cik=1826457) · [CSV](https://equitycapital.markets/filings.csv?cik=1826457)

---
Source page: https://equitycapital.markets/company/1826457 · Data: U.S. SEC EDGAR · CC BY 4.0